Here are the 10-Q quarterly reports from Caring Brands, Inc. (CABR) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CABR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CABR filings page.
Caring Brands, Inc., an emerging growth wellness products company, reported no revenue for the three and six months ended June 30, 2026, versus immaterial revenue a year earlier, and remains pre-commercial. Operating expenses rose sharply, driving a six‑month operating loss of $2.36 million and a net loss of $2.65 million, compared with a $1.20 million net loss in the prior‑year period.
Cash and cash equivalents were $1.82 million at June 30, 2026, after using $1.01 million in operating cash in the first half and receiving $3.87 million in PIPE financing. The Greentree $200,000 convertible note was fully converted to equity, leaving no debt outstanding. However, stockholders’ equity swung from $2.09 million at December 31, 2025 to a deficit of $(2.71) million, while $4.23 million of Series A convertible preferred stock is classified as mezzanine equity with a Triggering Event redemption feature. The company discloses going concern uncertainties and has received a Nasdaq delisting determination related to its equity deficiency, which it is appealing.
Caring Brands, Inc. reported a larger quarterly loss with no revenue as it continues early-stage development of its wellness products. For the three months ended March 31, 2026, the company generated no revenue and recorded a net loss of $2,008,476, compared with $538,770 a year earlier. Net loss attributable to common stockholders was $3,853,083, or $0.27 per share, reflecting significant accretion on redeemable preferred stock.
Operating expenses rose to $1,721,499, driven mainly by higher payroll, stock-based compensation, and professional fees tied to public company and capital markets activities. Interest expense of $286,989 was largely non-cash, linked to a convertible note that was fully converted into equity.
The company ended the quarter with cash and cash equivalents of $2,033,438 and total assets of $2,171,749. It completed a PIPE financing of Series A Convertible Redeemable Preferred Stock with approximately $3.6M stated value and repurchased 6,250,000 common shares for $3,075,000. Management believes current cash can fund operations for at least twelve months, but the filing highlights a going concern uncertainty, a Nasdaq stockholders’ equity deficiency notice, substantial accumulated deficit, and material weaknesses in internal controls.